Fibromyalgia: Presentation and Management with a Focus on Pharmacological Treatment
Open Access
- 1 January 2008
- journal article
- review article
- Published by Wiley in Pain Research and Management
- Vol. 13 (6) , 477-483
Abstract
Fibromyalgia is a condition with widespread muscle pain. Prevalence studies showed that 2% to 7% of the population have fibromyalgia, which affects approximately one million Canadians. Fibromyalgia is most common in women, but it also involves men and children. As with most chronic illnesses, the causes of fibromyalgia are unknown. However, recent research supports underlying abnormalities in the central nervous system, which supports fibromyalgia as a chronic disease state and valid clinical entity. Pain is the primary symptom, often accompanied by overwhelming fatigue, sleep dysfunction and cognitive impairment. In 1990, the American College of Rheumatology developed diagnostic criteria for the diagnosis of fibromyalgia. Lifestyle changes, including pacing of activities and aerobic exercise, are very important in managing fibromyalgia symptoms. Emotional and behavioural therapy can also be helpful. Controlled trials of antidepressants, gabapentinoids, tramadol, zopiclone and sodium oxybate have shown effectiveness in fibromyalgia patients. Pregabalin and duloxetine were recently approved in the United States. Effective management of fibromyalgia is complex and requires a multidisciplinary treatment approach. Response and tolerance of different therapeutic interventions vary from patient to patient. Recent advances in the pathophysiology of fibromyalgia offer hope for new and improved therapies in the management of this disabling condition.Keywords
This publication has 49 references indexed in Scilit:
- Treatment Strategy in Fibromyalgia Syndrome: Where Are We Now?Seminars in Arthritis and Rheumatism, 2008
- Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆Pain, 2008
- EULAR evidence-based recommendations for the management of fibromyalgia syndromeAnnals of the Rheumatic Diseases, 2008
- Social functioning and peer relationships of adolescents with juvenile fibromyalgia syndromeArthritis Care & Research, 2007
- A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderPain, 2005
- A randomized, double‐blind, placebo‐controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medicationsArthritis & Rheumatism, 2005
- Venlafaxine Treatment of FibromyalgiaAnnals of Pharmacotherapy, 2003
- Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgiaArthritis & Rheumatism, 2002
- Cognitive behavioral treatment of fibromyalgia syndrome: preliminary findings.1992
- Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosisPain, 1988